Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.14 trillion and total revenue of $110.22 billion.
Market Cap
1.14T
Revenue
110.22B
Profits
-41.27B
PE Ratio
n/a
Profit Margin
-37.44%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 109.09B | 1.13% | 953,349 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 72.73B | 0.82% | 589,042 | 14.92B |
| 3 | ARGX | argenx SE | 49.10B | -0.65% | 354,316 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.39B | -0.29% | 926,772 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 34.70B | -1.54% | 210,369 | 5.74B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.15B | -0.49% | 2,514,425 | - |
| 7 | RPRX | Royalty Pharma plc | 29.25B | 1.18% | 3,764,599 | 2.44B |
| 8 | BNTX | BioNTech SE | 23.80B | 1.19% | 1,035,634 | 3.23B |
| 9 | INSM | Insmed Incorporated | 21.97B | -3.48% | 8,588,262 | 819.56M |
| 10 | MRNA | Moderna, Inc. | 21.57B | 11.97% | 20,925,853 | 2.23B |
| 11 | ROIV | Roivant Sciences Ltd. | 20.44B | 0.99% | 5,604,941 | 13.31M |
| 12 | INCY | Incyte Corporation | 19.69B | 0.81% | 877,843 | 5.36B |
| 13 | GMAB | Genmab A/S | 15.88B | -2.33% | 5,919,572 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 14.82B | -3.04% | 674,239 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.17B | -0.52% | 741,275 | 4.44B |
| 16 | SMMT | Summit Therapeutics Inc. | 14.03B | 5.42% | 3,878,917 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.20B | -0.09% | 5,401,590 | 579.96M |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.51B | -0.41% | 1,656,234 | 1.06B |
| 19 | EXEL | Exelixis, Inc. | 12.11B | 4.22% | 2,179,092 | 2.38B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.76B | -4.64% | 379,310 | 1.13B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.19B | -1.29% | 574,233 | 708.24M |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.45B | -0.11% | 1,972,418 | 3.24B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.24B | -6.75% | 2,700,204 | 622.01M |
| 24 | ABVX | ABIVAX Société Anonyme | 9.83B | -1.53% | 917,599 | 5.37M |
| 25 | CYTK | Cytokinetics, Incorporated | 9.57B | 3.53% | 5,791,776 | 105.82M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.20B | -0.98% | 339,040 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.01B | 3.04% | 470,599 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.91B | 9.66% | 16,203,767 | 140.98M |
| 29 | NUVL | Nuvalent, Inc. | 8.32B | 2.81% | 579,883 | - |
| 30 | PCVX | Vaxcyte, Inc. | 7.65B | 2.97% | 1,917,190 | - |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.60B | -1.64% | 1,706,545 | 1.40B |
| 32 | TECH | Bio-Techne Corporation | 7.57B | -5.01% | 3,850,168 | 1.21B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.08B | 1.71% | 446,110 | 51.48M |
| 34 | MIRM | Mirum Pharmaceuticals, Inc. | 6.53B | 4.11% | 1,791,124 | 569.61M |
| 35 | SYRE | Spyre Therapeutics, Inc. | 6.52B | 2.66% | 840,633 | - |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.45B | -2.14% | 882,559 | 217.17M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.39B | 0.52% | 505,004 | 74.06M |
| 38 | CELC | Celcuity Inc. | 6.34B | 0.27% | 799,756 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.20B | 1.49% | 768,714 | - |
| 40 | CGON | CG Oncology, Inc. | 6.14B | 0.64% | 1,143,042 | 5.07M |
| 41 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.05% | 682,356 | 15.00M |
| 42 | PTCT | PTC Therapeutics, Inc. | 6.11B | 14.27% | 5,836,406 | 827.11M |
| 43 | BLTE | Belite Bio, Inc | 6.09B | -0.72% | 59,996 | - |
| 44 | TGTX | TG Therapeutics, Inc. | 6.07B | -0.40% | 3,729,567 | 700.35M |
| 45 | COGT | Cogent Biosciences, Inc. | 5.94B | -0.14% | 896,099 | - |
| 46 | IMVT | Immunovant, Inc. | 5.89B | 6.32% | 2,400,352 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.80B | 4.18% | 1,049,134 | - |
| 48 | CORT | Corcept Therapeutics Incorporated | 5.61B | 2.41% | 872,698 | 769.10M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.46B | 0.79% | 920,547 | 7.50M |
| 50 | CRSP | CRISPR Therapeutics AG | 5.29B | 4.60% | 1,733,487 | 4.10M |
| 51 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | 0.05% | 7,067,495 | 1.11B |
| 52 | LEGN | Legend Biotech Corporation | 5.20B | -1.58% | 2,600,698 | 1.03B |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 4.74B | 1.45% | 517,046 | 1.34M |
| 54 | CAI | Caris Life Sciences, Inc. | 4.57B | -18.60% | 8,874,447 | 907.29M |
| 55 | NAMS | NewAmsterdam Pharma Company N.V. | 4.45B | 11.13% | 4,805,885 | 22.57M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 4.44B | 5.27% | 249,977 | 274.48M |
| 57 | MANE | Veradermics, Incorporated | 4.37B | -1.59% | 496,371 | - |
| 58 | TVTX | Travere Therapeutics, Inc. | 3.96B | -0.14% | 2,266,026 | 536.20M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.95B | -13.82% | 4,707,631 | 18.07M |
| 60 | ORKA | Oruka Therapeutics, Inc. | 3.87B | 0.81% | 942,664 | - |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.84B | -0.71% | 2,084,366 | 1.10B |
| 62 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.80B | -0.06% | 4,480,768 | 588.99M |
| 63 | EWTX | Edgewise Therapeutics, Inc. | 3.80B | -0.73% | 1,015,652 | - |
| 64 | VKTX | Viking Therapeutics, Inc. | 3.64B | -0.79% | 1,448,659 | - |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.62B | 0.19% | 199,035 | 803.79M |
| 66 | TNGX | Tango Therapeutics, Inc. | 3.32B | -1.96% | 1,511,454 | 62.38M |
| 67 | BEAM | Beam Therapeutics Inc. | 3.22B | 2.70% | 2,853,187 | 164.01M |
| 68 | RCUS | Arcus Biosciences, Inc. | 3.19B | 2.34% | 967,754 | 236.00M |
| 69 | ERAS | Erasca, Inc. | 3.15B | -2.69% | 3,134,889 | - |
| 70 | DNLI | Denali Therapeutics Inc. | 3.11B | -0.46% | 1,945,846 | - |
| 71 | ALMS | Alumis Inc. | 3.01B | -0.42% | 977,299 | 24.05M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.91B | 0.40% | 1,741,668 | - |
| 73 | KLRA | Kailera Therapeutics, Inc. | 2.78B | -4.45% | 446,208 | - |
| 74 | GPCR | Structure Therapeutics Inc. | 2.78B | -0.13% | 803,107 | - |
| 75 | NKTR | Nektar Therapeutics | 2.76B | -1.78% | 722,769 | 55.63M |
| 76 | SLNO | Soleno Therapeutics, Inc. | 2.76B | - | 1,209,956 | 285.01M |
| 77 | CLDX | Celldex Therapeutics, Inc. | 2.67B | 1.95% | 794,142 | 865.00K |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 2.65B | 2.47% | 2,715,306 | 415.62M |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.63B | -4.30% | 1,005,126 | 535.08M |
| 80 | IRON | Disc Medicine, Inc. | 2.61B | 1.08% | 656,316 | - |
| 81 | VERA | Vera Therapeutics, Inc. | 2.60B | 0.86% | 797,468 | - |
| 82 | RARE | Ultragenyx Pharmaceutical Inc. | 2.56B | -0.04% | 1,557,063 | 670.00M |
| 83 | KOD | Kodiak Sciences Inc. | 2.56B | -6.11% | 721,446 | - |
| 84 | IMNM | Immunome, Inc. | 2.54B | 1.13% | 625,743 | 6.94M |
| 85 | IDYA | IDEAYA Biosciences, Inc. | 2.49B | 0.28% | 545,767 | 225.27M |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.48B | 1.14% | 606,599 | - |
| 87 | RLAY | Relay Therapeutics, Inc. | 2.44B | 2.00% | 1,830,600 | 10.68M |
| 88 | MLYS | Mineralys Therapeutics, Inc. | 2.44B | 0.65% | 894,873 | - |
| 89 | DFTX | Definium Therapeutics, Inc. | 2.40B | -4.96% | 2,208,807 | - |
| 90 | OCUL | Ocular Therapeutix, Inc. | 2.11B | -0.31% | 2,097,015 | 52.04M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.11B | -4.06% | 4,078,406 | 2.18B |
| 92 | NBTX | Nanobiotix S.A. | 2.11B | 6.76% | 56,629 | 38.27M |
| 93 | ZLAB | Zai Lab Limited | 2.09B | -5.92% | 1,255,208 | 453.28M |
| 94 | TRVI | Trevi Therapeutics, Inc. | 2.06B | 3.20% | 1,990,825 | - |
| 95 | STOK | Stoke Therapeutics, Inc. | 2.05B | 0.30% | 693,133 | 32.08M |
| 96 | TYRA | Tyra Biosciences, Inc. | 2.04B | 4.32% | 896,093 | - |
| 97 | AAPG | Ascentage Pharma Group International | 2.00B | -0.92% | 2,314 | 82.08M |
| 98 | SION | Sionna Therapeutics, Inc. | 2.00B | 2.12% | 405,348 | - |
| 99 | ANAB | AnaptysBio, Inc. | 1.99B | 3.54% | 490,505 | 234.60M |
| 100 | NTLA | Intellia Therapeutics, Inc. | 1.97B | 2.77% | 5,804,319 | 67.67M |
| 101 | PHVS | Pharvaris N.V. | 1.97B | 1.38% | 572,617 | - |
| 102 | INBX | Inhibrx Biosciences, Inc. | 1.96B | 7.89% | 398,278 | 1.30M |
| 103 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | 0.59% | 1,541,877 | 298.30M |
| 104 | TSHA | Taysha Gene Therapies, Inc. | 1.96B | 2.10% | 2,179,748 | 7.47M |
| 105 | MBX | MBX Biosciences, Inc. | 1.95B | 18.02% | 1,883,246 | - |
| 106 | OCS | Oculis Holding AG | 1.93B | 4.99% | 484,934 | 1.51M |
| 107 | SNDX | Syndax Pharmaceuticals, Inc. | 1.90B | 4.63% | 2,177,927 | 217.17M |
| 108 | ADMA | ADMA Biologics, Inc. | 1.89B | -3.54% | 10,208,409 | 509.86M |
| 109 | MESO | Mesoblast Limited | 1.88B | -0.41% | 100,789 | 65.38M |
| 110 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 3.10% | 88,692 | 1.20B |
| 111 | RAPP | Rapport Therapeutics, Inc. | 1.82B | -4.73% | 373,537 | 20.00M |
| 112 | HRMY | Harmony Biosciences Holdings, Inc. | 1.79B | -1.37% | 750,798 | 899.11M |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | 1.53% | 13,648,216 | 66.41M |
| 114 | CAPR | Capricor Therapeutics, Inc. | 1.76B | -10.49% | 3,708,650 | 11.13M |
| 115 | ZYME | Zymeworks Inc. | 1.74B | -10.19% | 1,454,525 | 81.26M |
| 116 | QURE | uniQure N.V. | 1.74B | 14.53% | 6,719,189 | 18.09M |
| 117 | GENB | Generate Biomedicines, Inc. | 1.74B | 0.52% | 291,663 | 30.30M |
| 118 | PVLA | Palvella Therapeutics, Inc. | 1.74B | 7.09% | 231,545 | - |
| 119 | VRDN | Viridian Therapeutics, Inc. | 1.71B | -2.29% | 4,372,622 | 70.92M |
| 120 | VCEL | Vericel Corporation | 1.71B | -4.75% | 1,541,572 | 292.09M |
| 121 | NRIX | Nurix Therapeutics, Inc. | 1.71B | 1.47% | 1,293,838 | 71.78M |
| 122 | INVA | Innoviva, Inc. | 1.69B | 0.39% | 540,361 | 420.69M |
| 123 | ARDX | Ardelyx, Inc. | 1.67B | -2.87% | 5,863,188 | 427.68M |
| 124 | NUVB | Nuvation Bio Inc. | 1.67B | -0.42% | 2,918,421 | 143.05M |
| 125 | NVAX | Novavax, Inc. | 1.66B | 9.53% | 13,354,045 | 596.34M |
| 126 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | 0.94% | 582,938 | 66.05M |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.64B | -2.12% | 547,093 | 42.95M |
| 128 | IOVA | Iovance Biotherapeutics, Inc. | 1.62B | 1.97% | 20,688,669 | 285.61M |
| 129 | ABCL | AbCellera Biologics Inc. | 1.60B | 8.71% | 10,843,234 | 75.13M |
| 130 | VIR | Vir Biotechnology, Inc. | 1.54B | -1.62% | 1,611,672 | 65.50M |
| 131 | IMTX | Immatics N.V. | 1.52B | 2.06% | 376,072 | 56.67M |
| 132 | IMCR | Immunocore Holdings plc | 1.50B | -3.40% | 130,017 | 412.81M |
| 133 | PGEN | Precigen, Inc. | 1.49B | 1.45% | 4,873,575 | 9.68M |
| 134 | BHVN | Biohaven Ltd. | 1.48B | 1.23% | 1,978,618 | - |
| 135 | BCAX | Bicara Therapeutics Inc. | 1.48B | -2.21% | 377,373 | - |
| 136 | ATAI | AtaiBeckley Inc. | 1.48B | 0.50% | 3,860,158 | 4.09M |
| 137 | FTRE | Fortrea Holdings Inc. | 1.46B | -0.90% | 1,391,417 | 2.71B |
| 138 | DMRA | Damora Therapeutics, Inc. | 1.46B | -3.32% | 171,343 | - |
| 139 | MAZE | Maze Therapeutics, Inc. | 1.44B | 2.20% | 534,976 | 2.50M |
| 140 | URGN | UroGen Pharma Ltd. | 1.43B | 10.57% | 1,696,667 | 140.49M |
| 141 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | 0.04% | 2,345,168 | 73.62M |
| 142 | WVE | Wave Life Sciences Ltd. | 1.38B | -0.83% | 2,551,033 | 71.80M |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.37B | 2.25% | 270,996 | - |
| 144 | GHRS | GH Research PLC | 1.33B | 1.95% | 161,072 | - |
| 145 | SVRA | Savara Inc. | 1.33B | 1.36% | 816,139 | - |
| 146 | CRVS | Corvus Pharmaceuticals, Inc. | 1.31B | 6.58% | 980,530 | - |
| 147 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | -1.52% | 592,428 | - |
| 148 | JBIO | Jade Biosciences, Inc. | 1.27B | 6.56% | 697,493 | - |
| 149 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.25B | 23.10% | 11,244,657 | 204.73M |
| 150 | MLTX | MoonLake Immunotherapeutics | 1.24B | -0.81% | 961,898 | - |
| 151 | MPLT | MapLight Therapeutics, Inc. | 1.24B | -6.16% | 292,229 | - |
| 152 | DBVT | DBV Technologies S.A. | 1.19B | -1.30% | 127,428 | 5.74M |
| 153 | ZBIO | Zenas BioPharma, Inc. | 1.17B | 1.92% | 289,146 | 10.00M |
| 154 | EYPT | EyePoint, Inc. | 1.15B | 1.86% | 661,536 | 7.61M |
| 155 | AVLN | Avalyn Pharma Inc. | 1.14B | 1.49% | 290,424 | - |
| 156 | IVA | Inventiva S.A. | 1.11B | 0.37% | 235,421 | 7.94M |
| 157 | COAG | Hemab Therapeutics Holdings, Inc. | 1.11B | -2.41% | 207,219 | - |
| 158 | MNKD | MannKind Corporation | 1.09B | -0.85% | 9,544,170 | 360.78M |
| 159 | SEPN | Septerna, Inc. | 1.07B | -0.46% | 208,365 | 45.95M |
| 160 | AKTS | Aktis Oncology, Inc. | 1.03B | -1.27% | 117,619 | 6.50M |
| 161 | OMER | Omeros Corporation | 1.02B | -3.48% | 863,195 | - |
| 162 | SANA | Sana Biotechnology, Inc. | 974.02M | 0.29% | 1,635,183 | - |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 965.87M | -0.57% | 628,931 | 204.89M |
| 164 | XNCR | Xencor, Inc. | 953.46M | 4.47% | 899,514 | 97.36M |
| 165 | ANNX | Annexon, Inc. | 932.26M | 3.08% | 2,011,730 | - |
| 166 | SLS | SELLAS Life Sciences Group, Inc. | 924.51M | 1.62% | 3,435,226 | - |
| 167 | ABSI | Absci Corporation | 919.84M | 2.61% | 7,341,562 | 1.84M |
| 168 | VOR | Vor Biopharma Inc. | 917.91M | 5.35% | 1,173,333 | - |
| 169 | PHAR | Pharming Group N.V. | 916.90M | 8.17% | 19,569 | 369.49M |
| 170 | LBRX | LB Pharmaceuticals Inc | 916.76M | -0.03% | 69,601 | - |
| 171 | ORIC | ORIC Pharmaceuticals, Inc. | 916.13M | 0.45% | 1,258,171 | - |
| 172 | MGTX | MeiraGTx Holdings plc | 908.91M | 1.45% | 380,411 | 81.39M |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 894.21M | -1.15% | 625,194 | - |
| 174 | GERN | Geron Corporation | 891.71M | -4.79% | 12,746,103 | 196.12M |
| 175 | DSGN | Design Therapeutics, Inc. | 888.14M | 0.85% | 402,992 | - |
| 176 | TBPH | Theravance Biopharma, Inc. | 876.92M | -0.06% | 237,595 | 109.78M |
| 177 | AURA | Aura Biosciences, Inc. | 871.84M | 2.44% | 1,047,952 | - |
| 178 | SPRY | ARS Pharmaceuticals, Inc. | 867.89M | -2.89% | 1,272,300 | 84.28M |
| 179 | CTMX | CytomX Therapeutics, Inc. | 866.42M | -0.50% | 5,057,557 | 35.54M |
| 180 | JANX | Janux Therapeutics, Inc. | 864.45M | -2.51% | 865,870 | 13.73M |
| 181 | ABUS | Arbutus Biopharma Corporation | 854.72M | -0.23% | 752,854 | 14.08M |
| 182 | SPTX | Seaport Therapeutics, Inc. | 851.10M | 3.55% | 304,105 | - |
| 183 | ANRO | Alto Neuroscience, Inc. | 850.38M | 0.79% | 171,305 | - |
| 184 | LXRX | Lexicon Pharmaceuticals, Inc. | 847.36M | 19.05% | 7,018,740 | 69.64M |
| 185 | KURA | Kura Oncology, Inc. | 836.14M | 1.07% | 889,210 | 67.48M |
| 186 | EVMN | Evommune, Inc. | 825.54M | 1.87% | 413,508 | 10.00M |
| 187 | DRUG | Bright Minds Biosciences Inc. | 804.32M | -3.74% | 149,658 | - |
| 188 | ALLO | Allogene Therapeutics, Inc. | 784.27M | 0.44% | 4,476,510 | 22.00K |
| 189 | SGP | SpyGlass Pharma, Inc. | 782.52M | -7.80% | 31,482 | - |
| 190 | ODTX | Odyssey Therapeutics, Inc. | 774.60M | -8.78% | 3,171,335 | 2.98M |
| 191 | RLMD | Relmada Therapeutics, Inc. | 767.78M | -1.48% | 830,544 | - |
| 192 | DRTS | Alpha Tau Medical Ltd. | 748.96M | 8.41% | 492,868 | - |
| 193 | SLDB | Solid Biosciences Inc. | 715.46M | 2.83% | 924,818 | - |
| 194 | ACRS | Aclaris Therapeutics, Inc. | 688.54M | 1.44% | 1,205,871 | 8.37M |
| 195 | TENX | Tenax Therapeutics, Inc. | 686.52M | 0.09% | 929,454 | - |
| 196 | GYRE | Gyre Therapeutics, Inc. | 682.55M | 5.66% | 52,902 | 117.05M |
| 197 | TRAX | First Tracks Biotherapeutics, Inc. | 678.99M | 9.65% | 355,232 | - |
| 198 | STRO | Sutro Biopharma, Inc. | 666.69M | 1.03% | 237,195 | 102.48M |
| 199 | ZVRA | Zevra Therapeutics, Inc. | 657.95M | 1.18% | 2,650,226 | 122.29M |
| 200 | ARVN | Arvinas, Inc. | 652.27M | -0.79% | 595,321 | 262.60M |
| 201 | CABA | Cabaletta Bio, Inc. | 632.63M | -3.00% | 4,663,327 | - |
| 202 | CBIO | Crescent Biopharma, Inc. | 623.38M | 4.22% | 243,218 | 11.88M |
| 203 | CRMD | CorMedix Inc. | 621.26M | - | 858,923 | 311.71M |
| 204 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 613.05M | -2.54% | 238,159 | - |
| 205 | CADL | Candel Therapeutics, Inc. | 611.81M | 7.19% | 2,533,637 | - |
| 206 | FBRX | Forte Biosciences, Inc. | 609.18M | -8.22% | 344,785 | - |
| 207 | ALT | Altimmune, Inc. | 600.08M | 1.64% | 2,858,248 | 41.00K |
| 208 | AGMB | AgomAb Therapeutics NV | 597.38M | 6.22% | 107,862 | - |
| 209 | DNA | Ginkgo Bioworks Holdings, Inc. | 583.35M | -13.47% | 2,212,978 | 151.40M |
| 210 | PRME | Prime Medicine, Inc. | 579.78M | 3.05% | 2,446,468 | 4.03M |
| 211 | AVTX | Avalo Therapeutics, Inc. | 576.23M | -5.68% | 1,780,362 | 59.00K |
| 212 | KYTX | Kyverna Therapeutics, Inc. | 565.96M | 0.54% | 461,495 | - |
| 213 | PRTA | Prothena Corporation plc | 561.75M | 2.00% | 798,770 | 57.94M |
| 214 | PROK | ProKidney Corp. | 561.65M | -1.06% | 719,130 | 893.00K |
| 215 | TECX | Tectonic Therapeutic, Inc. | 547.21M | 7.93% | 432,689 | - |
| 216 | RGNX | REGENXBIO Inc. | 544.56M | 1.25% | 1,379,404 | 170.44M |
| 217 | CLYM | Climb Bio, Inc. | 543.13M | -4.53% | 1,139,467 | - |
| 218 | CTNM | Contineum Therapeutics, Inc. | 542.49M | -0.68% | 133,371 | - |
| 219 | EIKN | Eikon Therapeutics, Inc. | 539.22M | 8.62% | 567,029 | - |
| 220 | MDXG | MiMedx Group, Inc. | 536.20M | -2.44% | 1,766,755 | 389.42M |
| 221 | VALN | Valneva SE | 535.73M | 0.54% | 22,778 | 205.07M |
| 222 | ANL | Adlai Nortye Ltd. | 531.20M | -3.07% | 227,161 | 5.00M |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 530.08M | 2.11% | 832,112 | 88.24M |
| 224 | STTK | Shattuck Labs, Inc. | 517.74M | 9.42% | 1,574,191 | 1.00M |
| 225 | IMMX | Immix Biopharma, Inc. | 516.87M | 2.20% | 661,325 | - |
| 226 | OCGN | Ocugen, Inc. | 511.16M | 4.86% | 10,152,532 | 4.47M |
| 227 | XOMA | XOMA Royalty Corporation | 499.15M | 1.45% | 111,717 | 52.15M |
| 228 | UPB | Upstream Bio, Inc. | 494.68M | 1.11% | 456,143 | 2.85M |
| 229 | PRLD | Prelude Therapeutics Incorporated | 488.81M | -5.63% | 528,315 | 12.14M |
| 230 | OVID | Ovid Therapeutics Inc. | 484.50M | 2.56% | 1,516,148 | 7.25M |
| 231 | RIGL | Rigel Pharmaceuticals, Inc. | 481.79M | -0.76% | 299,364 | 299.77M |
| 232 | NGNE | Neurogene Inc. | 480.65M | -1.54% | 168,844 | 925.00K |
| 233 | SGMT | Sagimet Biosciences Inc. | 476.11M | 0.92% | 964,160 | - |
| 234 | ASMB | Assembly Biosciences, Inc. | 472.65M | -3.85% | 143,418 | 71.10M |
| 235 | FULC | Fulcrum Therapeutics, Inc. | 467.10M | 1.89% | 646,186 | 80.00M |
| 236 | EPRX | Eupraxia Pharmaceuticals Inc. | 463.21M | -0.27% | 94,575 | - |
| 237 | ZURA | Zura Bio Limited | 454.48M | 5.51% | 1,053,758 | - |
| 238 | LYEL | Lyell Immunopharma, Inc. | 451.02M | -3.64% | 62,024 | 31.00K |
| 239 | ADCT | ADC Therapeutics SA | 445.17M | -6.67% | 1,632,491 | 79.18M |
| 240 | ENTA | Enanta Pharmaceuticals, Inc. | 445.16M | 1.66% | 191,733 | 66.98M |
| 241 | AVIR | Atea Pharmaceuticals, Inc. | 434.55M | -1.99% | 239,830 | - |
| 242 | LXEO | Lexeo Therapeutics, Inc. | 431.93M | 0.17% | 994,001 | - |
| 243 | VSTM | Verastem, Inc. | 429.70M | -13.60% | 7,555,492 | 49.59M |
| 244 | MNPR | Monopar Therapeutics Inc. | 425.45M | 1.83% | 183,418 | - |
| 245 | IVVD | Invivyd, Inc. | 424.21M | 4.90% | 1,467,749 | 53.43M |
| 246 | PRTC | PureTech Health plc | 421.91M | 1.00% | 35,777 | 4.66M |
| 247 | BNTC | Benitec Biopharma Inc. | 420.65M | 1.15% | 169,237 | - |
| 248 | AUTL | Autolus Therapeutics plc | 417.84M | -2.48% | 1,204,350 | 75.39M |
| 249 | IPSC | Century Therapeutics, Inc. | 413.01M | -0.87% | 472,791 | 109.16M |
| 250 | LRMR | Larimar Therapeutics, Inc. | 412.42M | -0.75% | 1,496,786 | - |
| 251 | XFOR | X4 Pharmaceuticals, Inc. | 402.77M | 3.26% | 427,932 | 9.01M |
| 252 | RCKT | Rocket Pharmaceuticals, Inc. | 396.37M | -1.09% | 3,687,933 | - |
| 253 | PBYI | Puma Biotechnology, Inc. | 381.24M | 3.17% | 755,015 | 227.18M |
| 254 | VTVT | vTv Therapeutics Inc. | 380.72M | -1.16% | 22,461 | 17.00K |
| 255 | VNDA | Vanda Pharmaceuticals Inc. | 377.65M | -1.72% | 1,309,361 | 217.78M |
| 256 | YDES | YD Bio Limited | 373.40M | 0.38% | 2,814 | 510.36K |
| 257 | IRD | Opus Genetics, Inc. | 356.30M | -6.90% | 1,304,093 | 14.20M |
| 258 | IKT | Inhibikase Therapeutics, Inc. | 351.13M | 3.52% | 955,806 | 1.00 |
| 259 | LCTX | Lineage Cell Therapeutics, Inc. | 341.54M | - | 1,166,523 | 14.56M |
| 260 | NAUT | Nautilus Biotechnology, Inc. | 340.57M | -6.94% | 257,950 | - |
| 261 | DMAC | DiaMedica Therapeutics Inc. | 340.54M | -3.22% | 276,939 | - |
| 262 | IMRX | Immuneering Corporation | 337.72M | - | 497,109 | - |
| 263 | REPL | Replimune Group, Inc. | 336.07M | 21.86% | 15,126,250 | - |
| 264 | ABEO | Abeona Therapeutics Inc. | 335.61M | 2.25% | 853,847 | 5.82M |
| 265 | BCYC | Bicycle Therapeutics plc | 335.29M | -1.64% | 349,905 | 63.50M |
| 266 | NMRA | Neumora Therapeutics, Inc. | 334.32M | -5.67% | 2,129,663 | - |
| 267 | RZLT | Rezolute, Inc. | 333.43M | 3.88% | 710,494 | - |
| 268 | NAGE | Niagen Bioscience, Inc. | 332.81M | -0.48% | 1,787,471 | 130.42M |
| 269 | SRZN | Surrozen, Inc. | 332.66M | -5.82% | 69,192 | 7.49M |
| 270 | CMPX | Compass Therapeutics, Inc. | 329.56M | 1.10% | 6,529,813 | 850.00K |
| 271 | SLN | Silence Therapeutics plc | 329.23M | 0.29% | 326,796 | 839.00K |
| 272 | CCCC | C4 Therapeutics, Inc. | 325.03M | -1.01% | 1,345,555 | 35.95M |
| 273 | GLSI | Greenwich LifeSciences, Inc. | 316.71M | -3.22% | 75,974 | - |
| 274 | LENZ | LENZ Therapeutics, Inc. | 315.43M | 3.50% | 640,401 | 19.09M |
| 275 | ZNTL | Zentalis Pharmaceuticals, Inc. | 312.81M | 4.26% | 769,537 | 26.87M |
| 276 | NVCT | Nuvectis Pharma, Inc. | 309.02M | 12.89% | 182,535 | - |
| 277 | ARMP | Armata Pharmaceuticals, Inc. | 304.57M | -9.29% | 50,803 | 4.90M |
| 278 | EDIT | Editas Medicine, Inc. | 304.49M | 2.64% | 1,115,129 | 38.69M |
| 279 | NGEN | NervGen Pharma Corp. | 303.49M | -2.60% | 123,957 | - |
| 280 | PALI | Palisade Bio, Inc. | 301.36M | -9.55% | 3,037,700 | - |
| 281 | AVXL | Anavex Life Sciences Corp. | 298.40M | 3.21% | 735,530 | - |
| 282 | ELDN | Eledon Pharmaceuticals, Inc. | 294.75M | 0.52% | 1,112,094 | - |
| 283 | TARA | Protara Therapeutics, Inc. | 290.17M | -1.86% | 635,570 | - |
| 284 | SABS | SAB Biotherapeutics, Inc. | 288.83M | 0.49% | 6,027,641 | 114.70K |
| 285 | ACIU | AC Immune SA | 283.72M | -2.05% | 342,791 | 4.62M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 279.88M | 11.23% | 998,765 | - |
| 287 | FATE | Fate Therapeutics, Inc. | 277.91M | -1.65% | 2,848,836 | 6.65M |
| 288 | ACHV | Achieve Life Sciences, Inc. | 277.38M | 8.77% | 1,759,692 | - |
| 289 | CGEN | Compugen Ltd. | 274.21M | 1.40% | 337,768 | 72.76M |
| 290 | CLLS | Cellectis S.A. | 273.24M | -0.26% | 35,983 | 79.59M |
| 291 | CHRS | Coherus Oncology, Inc. | 269.88M | -0.57% | 676,081 | 42.17M |
| 292 | ARTV | Artiva Biotherapeutics, Inc. | 269.16M | -13.02% | 5,293,848 | 251.00K |
| 293 | HELP | Cybin Inc. | 265.69M | -0.56% | 619,730 | - |
| 294 | ARCT | Arcturus Therapeutics Holdings Inc. | 262.06M | 3.60% | 933,794 | 54.71M |
| 295 | FHTX | Foghorn Therapeutics Inc. | 260.69M | 5.71% | 194,539 | 28.22M |
| 296 | CDXS | Codexis, Inc. | 259.06M | 10.47% | 1,826,223 | 78.09M |
| 297 | NERV | Minerva Neurosciences, Inc. | 257.79M | -4.08% | 74,686 | - |
| 298 | NBP | NovaBridge Biosciences | 254.43M | -0.90% | 396,099 | - |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 254.15M | 6.00% | 172,223 | 1.78M |
| 300 | TRDA | Entrada Therapeutics, Inc. | 246.47M | -0.15% | 1,316,081 | 5.74M |
| 301 | VYGR | Voyager Therapeutics, Inc. | 244.71M | 2.27% | 639,750 | 36.49M |
| 302 | ADAG | Adagene Inc. | 243.81M | 3.07% | 103,468 | 7.67M |
| 303 | OBIO | Orchestra BioMed Holdings, Inc. | 241.92M | 2.80% | 197,111 | 33.48M |
| 304 | OABI | OmniAb, Inc. | 240.65M | 12.93% | 5,664,987 | 28.94M |
| 305 | FENC | Fennec Pharmaceuticals Inc. | 240.56M | 0.43% | 211,119 | 44.64M |
| 306 | KROS | Keros Therapeutics, Inc. | 238.84M | 3.69% | 394,560 | 244.06M |
| 307 | MIST | Milestone Pharmaceuticals Inc. | 235.49M | 1.59% | 602,330 | 1.55M |
| 308 | HUMA | Humacyte, Inc. | 235.34M | -1.85% | 5,588,500 | 2.04M |
| 309 | ALEC | Alector, Inc. | 233.15M | -13.93% | 720,453 | 18.42M |
| 310 | SLGL | Sol-Gel Technologies Ltd. | 231.64M | 1.90% | 11,289 | 19.39M |
| 311 | CAMP | Camp4 Therapeutics Corporation | 231.59M | 2.76% | 35,697 | 3.93M |
| 312 | HRTX | Heron Therapeutics, Inc. | 228.25M | -2.42% | 1,794,648 | 154.90M |
| 313 | NKTX | Nkarta, Inc. | 227.42M | 1.27% | 681,507 | - |
| 314 | CNTX | Context Therapeutics Inc. | 218.67M | 2.15% | 537,691 | - |
| 315 | TNYA | Tenaya Therapeutics, Inc. | 217.00M | 17.87% | 10,295,624 | 225.00K |
| 316 | MDWD | MediWound Ltd. | 212.96M | -4.05% | 82,807 | 16.96M |
| 317 | RNA | Atrium Therapeutics, Inc. | 202.78M | 0.85% | 109,772 | 18.62M |
| 318 | TLSA | Tiziana Life Sciences Ltd | 201.65M | 4.64% | 168,945 | - |
| 319 | UNCY | Unicycive Therapeutics, Inc. | 200.39M | 1.02% | 401,800 | - |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 200.15M | 3.45% | 262,913 | 13.11M |
| 321 | DTIL | Precision BioSciences, Inc. | 198.43M | 2.81% | 182,681 | 45.07M |
| 322 | WHWK | Whitehawk Therapeutics, Inc. | 196.23M | 0.76% | 54,000 | 7.15M |
| 323 | KPTI | Karyopharm Therapeutics Inc. | 194.77M | -2.37% | 295,537 | 146.07M |
| 324 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 194.39M | 0.83% | 240,983 | - |
| 325 | MGNX | MacroGenics, Inc. | 190.68M | 2.04% | 814,239 | 149.50M |
| 326 | CRBU | Caribou Biosciences, Inc. | 190.62M | 3.19% | 892,098 | 11.20M |
| 327 | IFRX | InflaRx N.V. | 186.52M | -2.64% | 7,488,472 | 33.82K |
| 328 | ENLV | Enlivex Ltd. | 185.61M | -4.12% | 341,255 | - |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 184.90M | 3.64% | 163,270 | - |
| 330 | ELTX | Elicio Therapeutics, Inc. | 182.31M | -1.00% | 105,243 | - |
| 331 | KRRO | Korro Bio, Inc. | 173.79M | -6.52% | 252,661 | 3.84M |
| 332 | PLYX | Polaryx Therapeutics, Inc. | 173.28M | -4.19% | 144,630 | - |
| 333 | PYXS | Pyxis Oncology, Inc. | 172.16M | 21.24% | 1,996,584 | 13.86M |
| 334 | BDTX | Black Diamond Therapeutics, Inc. | 171.33M | 9.93% | 1,663,364 | 70.00M |
| 335 | CNTN | Canton Strategic Holdings, Inc. | 171.10M | 1.34% | 355,236 | - |
| 336 | PRQR | ProQR Therapeutics N.V. | 166.47M | - | 663,962 | 19.19M |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 165.42M | 4.60% | 258,459 | 2.00M |
| 338 | KZIA | Kazia Therapeutics Limited | 165.00M | 7.68% | 386,407 | 1.27M |
| 339 | ANTX | AN2 Therapeutics, Inc. | 160.54M | -3.04% | 241,952 | - |
| 340 | IMUX | Immunic, Inc. | 158.17M | -1.02% | 221,519 | - |
| 341 | OKUR | OnKure Therapeutics, Inc. | 157.95M | -1.26% | 89,569 | - |
| 342 | MENS | Jyong Biotech Ltd. | 157.65M | - | 39,299 | - |
| 343 | PLX | Protalix BioTherapeutics, Inc. | 156.31M | -2.02% | 621,180 | 52.74M |
| 344 | MOLN | Molecular Partners AG | 155.41M | - | 5,856 | 856.30K |
| 345 | SPRB | Spruce Biosciences, Inc. | 152.68M | -0.12% | 25,166 | 697.00K |
| 346 | HURA | TuHURA Biosciences, Inc. | 151.32M | -0.83% | 490,494 | - |
| 347 | SPRO | Spero Therapeutics, Inc. | 148.23M | 1.99% | 355,976 | 66.80M |
| 348 | AGEN | Agenus Inc. | 146.68M | 1.87% | 621,821 | 114.20M |
| 349 | EDSA | Edesa Biotech, Inc. | 144.84M | -6.48% | 292,122 | - |
| 350 | IPHA | Innate Pharma S.A. | 138.49M | 2.92% | 6,801 | 10.57M |
| 351 | GALT | Galectin Therapeutics Inc. | 138.24M | -0.47% | 207,489 | - |
| 352 | GNLX | Genelux Corporation | 138.11M | 9.89% | 368,403 | 8.00K |
| 353 | NTHI | NeOnc Technologies Holdings, Inc. | 137.28M | -16.02% | 245,156 | 39.99K |
| 354 | VRCA | Verrica Pharmaceuticals Inc. | 137.26M | -3.03% | 110,370 | 35.58M |
| 355 | ALPS | Alps Group Inc | 136.63M | -1.55% | 30,226 | 3.74M |
| 356 | EQ | Equillium, Inc. | 133.41M | -1.40% | 239,920 | 4.39M |
| 357 | CNTB | Connect Biopharma Holdings Limited | 133.39M | 1.29% | 95,208 | 64.00K |
| 358 | ACOG | Alpha Cognition Inc. | 132.82M | 0.16% | 11,741 | 10.22M |
| 359 | PEPG | PepGen Inc. | 121.74M | -1.68% | 698,753 | - |
| 360 | GUTS | Fractyl Health, Inc. | 119.73M | 0.88% | 1,187,704 | 3.00K |
| 361 | INO | Inovio Pharmaceuticals, Inc. | 119.63M | 6.57% | 21,007,953 | 65.34K |
| 362 | AARD | Aardvark Therapeutics, Inc. | 118.68M | -2.86% | 84,003 | - |
| 363 | KLRS | Kalaris Therapeutics, Inc. | 116.80M | -1.36% | 41,396 | - |
| 364 | CUE | Cue Biopharma, Inc. | 113.94M | -2.04% | 244,602 | 27.47M |
| 365 | TTRX | Turn Therapeutics Inc. | 112.89M | -0.13% | 29,520 | - |
| 366 | CRDF | Cardiff Oncology, Inc. | 112.13M | 2.50% | 451,314 | 593.00K |
| 367 | BMEA | Biomea Fusion, Inc. | 111.34M | -5.52% | 1,089,301 | - |
| 368 | CBUS | Cibus, Inc. | 109.85M | -4.00% | 251,205 | 3.64M |
| 369 | CGTX | Cognition Therapeutics, Inc. | 108.12M | 4.31% | 694,269 | - |
| 370 | SEER | Seer, Inc. | 105.51M | -0.53% | 213,539 | 16.58M |
| 371 | ALDX | Aldeyra Therapeutics, Inc. | 104.36M | - | 827,590 | - |
| 372 | ONCY | Oncolytics Biotech Inc. | 103.34M | -1.12% | 633,786 | - |
| 373 | VANI | Vivani Medical, Inc. | 102.62M | -1.65% | 126,420 | - |
| 374 | NRXP | NRx Pharmaceuticals, Inc. | 101.75M | 0.65% | 984,405 | 1.23M |
| 375 | ANIX | Anixa Biosciences, Inc. | 100.58M | 1.35% | 77,116 | - |
| 376 | ENGN | enGene Therapeutics Inc. | 100.48M | -12.79% | 17,386,930 | - |
| 377 | COYA | Coya Therapeutics, Inc. | 96.41M | -2.14% | 165,654 | 7.95M |
| 378 | RANI | Rani Therapeutics Holdings, Inc. | 96.37M | 3.71% | 402,292 | 1.63M |
| 379 | RNTX | Rein Therapeutics Inc. | 95.21M | 4.27% | 2,321,770 | - |
| 380 | NRXS | NeurAxis, Inc. | 94.34M | -6.82% | 156,863 | 3.57M |
| 381 | LONA | LeonaBio, Inc. | 94.31M | 1.83% | 80,945 | - |
| 382 | ATYR | aTyr Pharma, Inc. | 92.79M | 2.66% | 905,145 | 190.00K |
| 383 | QTTB | Q32 Bio Inc. | 91.06M | -1.29% | 115,929 | 53.74M |
| 384 | ACET | Adicet Bio, Inc. | 89.78M | 2.76% | 96,772 | - |
| 385 | PMN | ProMIS Neurosciences, Inc. | 88.15M | - | 33,273 | - |
| 386 | ATHE | Alterity Therapeutics Limited | 86.63M | -0.21% | 5,150 | 4.43M |
| 387 | PTHS | Pelthos Therapeutics Inc. | 85.55M | 1.86% | 14,401 | 16.80M |
| 388 | OKYO | OKYO Pharma Limited | 85.54M | 0.62% | 44,567 | - |
| 389 | CSBR | Champions Oncology, Inc. | 83.60M | 0.50% | 20,658 | 57.95M |
| 390 | PYPD | PolyPid Ltd. | 83.58M | -1.24% | 33,973 | - |
| 391 | EXOZ | eXoZymes, Inc. | 81.57M | -3.80% | 4,039 | -700.00 |
| 392 | MAIA | MAIA Biotechnology, Inc. | 80.09M | 0.76% | 305,481 | - |
| 393 | FBIO | Fortress Biotech, Inc. | 79.39M | -0.42% | 97,289 | 63.26M |
| 394 | ANVS | Annovis Bio, Inc. | 78.73M | 0.88% | 739,646 | - |
| 395 | ACTU | Actuate Therapeutics, Inc. | 78.25M | -1.20% | 69,791 | - |
| 396 | GANX | Gain Therapeutics, Inc. | 77.63M | -2.67% | 337,981 | - |
| 397 | GOSS | Gossamer Bio, Inc. | 76.75M | -4.86% | 3,392,857 | 48.47M |
| 398 | ACRV | Acrivon Therapeutics, Inc. | 76.71M | -2.46% | 541,910 | - |
| 399 | RLYB | Rallybio Corporation | 76.07M | -1.91% | 89,363 | 858.00K |
| 400 | TCRX | TScan Therapeutics, Inc. | 75.73M | 4.13% | 1,276,982 | 9.14M |
| 401 | PLRX | Pliant Therapeutics, Inc. | 75.54M | -1.61% | 208,195 | - |
| 402 | PMVP | PMV Pharmaceuticals, Inc. | 75.19M | -0.70% | 274,969 | - |
| 403 | XBIT | XBiotech Inc. | 75.00M | -1.60% | 21,968 | - |
| 404 | MCRB | Seres Therapeutics, Inc. | 74.17M | -0.26% | 27,911 | 1.15M |
| 405 | KALA | KALA BIO, Inc. | 73.71M | 4,671.36% | 150,525 | - |
| 406 | ICCC | ImmuCell Corporation | 72.83M | -4.96% | 23,199 | 27.64M |
| 407 | ATRA | Atara Biotherapeutics, Inc. | 70.99M | -16.01% | 3,002,954 | 120.77M |
| 408 | OSTX | OS Therapies Incorporated | 69.78M | -2.35% | 299,976 | - |
| 409 | PDSB | PDS Biotechnology Corporation | 69.77M | 9.65% | 912,921 | - |
| 410 | MNOV | MediciNova, Inc. | 68.91M | -2.10% | 17,840 | 409.66K |
| 411 | IBO | Impact BioMedical Inc. | 67.82M | 0.30% | 48,211 | 32.00K |
| 412 | CING | Cingulate Inc. | 64.56M | 0.76% | 261,646 | - |
| 413 | HYFT | MindWalk Holdings Corp. | 63.08M | 5.83% | 246,352 | 20.70M |
| 414 | FLNA | Filana Therapeutics, Inc. | 62.80M | -4.41% | 420,497 | - |
| 415 | IMMP | Immutep Limited | 61.89M | 3.15% | 479,448 | 5.28M |
| 416 | IBIO | iBio, Inc. | 61.81M | 4.27% | 1,835,399 | 300.00K |
| 417 | BYSI | BeyondSpring Inc. | 61.27M | 4.93% | 5,906 | 1.88M |
| 418 | ENTX | Entera Bio Ltd. | 60.61M | -5.11% | 158,557 | 42.00K |
| 419 | LIXT | Lixte Biotechnology Holdings, Inc. | 59.95M | 4.67% | 124,361 | - |
| 420 | IMA | ImageneBio, Inc. | 59.17M | -10.49% | 75,400 | 800.00K |
| 421 | TIL | Instil Bio, Inc. | 55.34M | 1.62% | 16,397 | - |
| 422 | DWTX | Dogwood Therapeutics, Inc. | 55.11M | 5.77% | 83,060 | - |
| 423 | INKT | MiNK Therapeutics, Inc. | 54.82M | -1.34% | 8,396 | - |
| 424 | KZR | Kezar Life Sciences, Inc. | 53.86M | -0.95% | 616,015 | - |
| 425 | ESLA | Estrella Immunopharma, Inc. | 53.76M | -0.79% | 42,868 | - |
| 426 | MGX | Metagenomi Therapeutics, Inc. | 53.08M | -0.70% | 174,412 | 25.21M |
| 427 | HYPD | Hyperion DeFi, Inc. | 51.14M | 0.84% | 691,942 | 813.46K |
| 428 | RADX | Radiopharm Theranostics Limited | 48.76M | -3.61% | 80,665 | 10.86M |
| 429 | ATOS | Atossa Therapeutics, Inc. | 48.22M | -1.23% | 31,402 | - |
| 430 | XLO | Xilio Therapeutics, Inc. | 46.31M | -0.90% | 22,946 | 43.77M |
| 431 | NTRB | Nutriband Inc. | 45.58M | -1.06% | 17,904 | 2.04M |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 44.70M | -1.52% | 76,575 | - |
| 433 | LITS | Lite Strategy, Inc. | 44.36M | 7.02% | 969,335 | - |
| 434 | PSTV | Plus Therapeutics, Inc. | 42.00M | 2.86% | 108,892 | 5.21M |
| 435 | ATNM | Actinium Pharmaceuticals, Inc. | 40.84M | 7.38% | 82,271 | 90.00K |
| 436 | DARE | Daré Bioscience, Inc. | 40.04M | -5.50% | 560,142 | 1.03M |
| 437 | ALGS | Aligos Therapeutics, Inc. | 39.85M | 6.80% | 318,583 | 4.71M |
| 438 | MREO | Mereo BioPharma Group plc | 39.84M | 4.00% | 1,408,216 | 500.00K |
| 439 | TVRD | Tvardi Therapeutics, Inc. | 39.21M | -0.71% | 47,984 | - |
| 440 | RNXT | RenovoRx, Inc. | 38.91M | -1.87% | 311,907 | 1.12M |
| 441 | INMB | INmune Bio Inc. | 38.02M | - | 240,374 | 50.00K |
| 442 | CRVO | CervoMed Inc. | 36.57M | 3.95% | 60,118 | 4.01M |
| 443 | GRCE | Grace Therapeutics, Inc. | 36.21M | 4.00% | 302,936 | - |
| 444 | EVAX | Evaxion A/S | 36.20M | 6.63% | 36,792 | 7.53M |
| 445 | VERU | Veru Inc. | 35.95M | -1.75% | 26,458 | 16.89M |
| 446 | NXTC | NextCure, Inc. | 35.21M | -4.13% | 9,494 | - |
| 447 | PLUR | Pluri Inc. | 35.03M | 4.34% | 4,567 | 1.34M |
| 448 | APLM | Apollomics, Inc. | 33.93M | -2.83% | 1,108 | 8.84M |
| 449 | NNVC | NanoViricides, Inc. | 33.47M | 9.15% | 426,147 | - |
| 450 | HOWL | Werewolf Therapeutics, Inc. | 33.05M | 9.68% | 2,431,868 | 1.14M |
| 451 | PTN | Palatin Technologies, Inc. | 32.79M | 3.02% | 2,483 | 8.96M |
| 452 | BOLD | Boundless Bio, Inc. | 32.28M | -5.88% | 399,744 | - |
| 453 | SNSE | Sensei Biotherapeutics, Inc. | 31.36M | -1.52% | 16,235 | - |
| 454 | TVGN | Tevogen Bio Holdings Inc. | 31.15M | - | 8,843 | - |
| 455 | NRSN | NeuroSense Therapeutics Ltd. | 31.11M | 0.34% | 80,310 | - |
| 456 | IGC | IGC Pharma, Inc. | 30.73M | -2.54% | 447,642 | 1.11M |
| 457 | SNTI | Senti Biosciences Holdings, Inc. | 30.70M | 0.07% | 58,823 | 22.00K |
| 458 | PLRZ | Polyrizon Ltd. | 30.59M | 15.56% | 153,844 | - |
| 459 | BCTX | BriaCell Therapeutics Corp. | 30.35M | 2.20% | 79,087 | - |
| 460 | SKYE | Skye Bioscience, Inc. | 30.30M | -3.96% | 106,532 | - |
| 461 | NEUP | Neuphoria Therapeutics Inc. | 28.63M | -0.56% | 36,277 | 14.99M |
| 462 | TPST | Tempest Therapeutics, Inc. | 28.54M | 1.02% | 83,419 | - |
| 463 | QNTM | Quantum BioPharma Ltd. | 28.53M | -2.59% | 118,020 | - |
| 464 | LSTA | Lisata Therapeutics, Inc. | 28.45M | -2.48% | 19,847 | 170.00K |
| 465 | KYNB | Kyntra Bio, Inc. | 28.13M | -2.11% | 4,876 | 6.44M |
| 466 | DYAI | Dyadic International, Inc. | 27.93M | 2.89% | 348,063 | 3.09M |
| 467 | BRNS | Barinthus Biotherapeutics plc | 27.37M | - | 19,094 | 14.97M |
| 468 | ABVC | ABVC BioPharma, Inc. | 26.19M | -3.64% | 67,734 | 797.92K |
| 469 | SER | Serina Therapeutics, Inc. | 26.07M | -3.31% | 40,751 | 130.00K |
| 470 | JSPR | Jasper Therapeutics, Inc. | 25.93M | 1.97% | 114,149 | - |
| 471 | CELU | Celularity Inc. | 25.37M | -3.04% | 126,086 | 26.55M |
| 472 | LGVN | Longeveron Inc. | 24.75M | -0.77% | 466,811 | 1.20M |
| 473 | MRKR | Marker Therapeutics, Inc. | 24.34M | 1.39% | 41,893 | 3.55M |
| 474 | VTGN | Vistagen Therapeutics, Inc. | 24.19M | 4.04% | 1,181,689 | 789.00K |
| 475 | ALLR | Allarity Therapeutics, Inc. | 23.96M | 3.33% | 355,322 | 320.00K |
| 476 | AEON | AEON Biopharma, Inc. | 23.68M | -1.10% | 61,820 | - |
| 477 | LTRN | Lantern Pharma Inc. | 23.54M | 2.94% | 118,012 | - |
| 478 | OTLK | Outlook Therapeutics, Inc. | 23.15M | 2.60% | 3,233,782 | 205.70K |
| 479 | CRIS | Curis, Inc. | 22.43M | -2.77% | 223,254 | 9.44M |
| 480 | TRAW | Traws Pharma, Inc. | 22.14M | 28.24% | 89,497,525 | 2.79M |
| 481 | VYNE | VYNE Therapeutics Inc. | 22.01M | -1.92% | 72,194 | 570.00K |
| 482 | XCUR | Exicure, Inc. | 21.48M | 0.60% | 9,904 | 500.00K |
| 483 | GRDX | GridAI Technologies Corp. | 21.20M | 20.00% | 259,891 | - |
| 484 | QNCX | Quince Therapeutics, Inc. | 20.86M | -1.54% | 1,246,700 | - |
| 485 | COCP | Cocrystal Pharma, Inc. | 19.85M | 3.60% | 191,362 | - |
| 486 | KTTA | Pasithea Therapeutics Corp. | 19.83M | -5.32% | 187,717 | - |
| 487 | LPCN | Lipocine Inc. | 19.02M | -0.84% | 188,492 | 2.00M |
| 488 | OSRH | OSR Holdings, Inc. | 18.90M | -17.45% | 2,785,784 | 2.91M |
| 489 | CVKD | Cadrenal Therapeutics, Inc. | 18.75M | 1.16% | 65,332 | - |
| 490 | ICU | SeaStar Medical Holding Corporation | 17.95M | -7.61% | 86,392 | 1.23M |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 17.35M | -2.16% | 865,126 | 3.94M |
| 492 | TOVX | Theriva Biologics, Inc. | 16.25M | -1.67% | 1,239,705 | 300.00K |
| 493 | INAB | IN8bio, Inc. | 15.56M | -1.25% | 42,515 | - |
| 494 | NCEL | NewcelX Ltd. | 15.32M | 3.70% | 25,274 | - |
| 495 | LEXX | Lexaria Bioscience Corp. | 15.12M | -4.82% | 269,539 | 368.00K |
| 496 | GNTA | Genenta Science S.p.A. | 14.77M | -2.20% | 53,682 | - |
| 497 | HIND | Vyome Holdings, Inc. | 14.46M | -1.90% | 19,911 | 319.71K |
| 498 | BLRX | BioLineRx Ltd. | 14.41M | -0.97% | 12,773 | 1.18M |
| 499 | CVM | CEL-SCI Corporation | 13.76M | 6.25% | 353,979 | - |
| 500 | PASG | Passage Bio, Inc. | 13.50M | 3.19% | 112,480 | - |